Sign in

CIK 0001649094

  • Large accelerated filer

Vaxcyte, Inc.

Sign in to watch
Ticker
PCVX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464233385
Phone
+1 650-837-0111
Business address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
Former names
SutroVax, Inc.
  1. 4 Grant or award Director acquired 2,500 shares (grant or award)
  2. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 2,366 shares at an average $92.25 ($218,253)
  3. 4 Planned sale SVP, GEN COUNSEL & CORP SEC sold 5,000 shares at an average $91.49 ($457,434)
  4. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $92.45 ($1,386,794)
  5. 4 Planned sale CHIEF OPERATING OFFICER sold 8,000 shares at an average $92.49 ($739,885)
  6. 4 Planned sale PRESIDENT AND CFO sold 8,000 shares at an average $85.81 ($686,518)
  7. 4 Gift CHIEF EXECUTIVE OFFICER gave 710 shares (gift)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 2,366 shares at an average $103.89 ($245,796)
  13. 4 Planned sale SVP, GEN COUNSEL & CORP SEC sold 5,000 shares at an average $106.36 ($531,803)
  14. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $106.82 ($1,602,252)
  15. 4 Planned sale CHIEF OPERATING OFFICER sold 8,000 shares at an average $106.80 ($854,423)
  16. 4 Option exercise CHIEF OPERATING OFFICER acquired 5,049 shares (option exercise)
  17. 4 Option exercise PRESIDENT AND CFO acquired 19,108 shares (option exercise)
  18. 4 Planned sale PRESIDENT AND CFO sold 42,000 shares at an average $115.39 ($4,846,508)
  19. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 7,098 shares at an average $109.21 ($775,154)
  20. 4 Planned sale SVP, GEN COUNSEL & CORP SEC sold 5,000 shares at an average $109.27 ($546,353)

Page 6 of 22 · 421 filings